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The advent of the sulfonamide drugs has opened up a new 
phase of ther,apy in the field of medicine. At first, all or the 
work on the eff'ectivenbss of t.nese drugs was done on the emplrioal 
be.sis. Some o£ tne later work has attempted to find the mechanism 
of the drug's action on bacteria.,. It is the purpose of this 
• 
paper to review the liter�ture, to bring together the v&rious 
findings, am to attempt .e. correlation. 
The scope o£ this paper is int.ended to cover only the mode 
or action in the blood stream. Local applications, urinary tr&ct 
use, and large concentrations in vitro have a siightly dif'feren� 
action than in vivo action, and .are, therei'ore, avoided a.s much 
as possible in this writing'.. -As deemed necessary, in vitro 
exjl6riments will be ret'erred to for the purpose of explaining 
the in vivo mechanism.,. 
For the sake of simplieity, the paper shall not go into tbe 
detail of proving sulfanil�mide the active principal o£ prontoail, 
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Chemotheravy, the brain-child of Erhlich in l.904, has recently 
.added ,another member to its .family., This ird.'ant, the sulfonaii1ide 
drugs, is expt,riencing a very r&:pid rate of growth., How large 
will. be tne .final field. of' applications can only be postu.Lated at 
the present time. 
The birth of the drug took place in 1909 when Domagk, a 
German scientist, fowxl that an azo textile dye, which had been 
synthesized by Gel.mo in 1908, was therapeutic against mouse 
septicemia� This knowledge was lightly regarded, and le.ft to 
slumber for many years. In 1935, i,detzch .and Kl.arer took out a 
German patent for a brick-red dye which 1ate,r became known as 
"'Prontosil;•. They f oum this to be slightly toxic to animals, 
but did no further work on the dye ... 
It wiis in the later pa.rt of 1935 that Domagk unsa.rthed his 
ear.lier ax.pt:irimant •nd started his investigations with l'rontosil .. 
His rtisu.lts or nine months work were published in 1956, where h� 
stated that prontosil, a relatively non-toxic reu dye, when givan 
by mouth in sm.al1 doses, prevented the evolution of' otherwise 
t:atal hanolytic streptococcal infection in miceJ controlled am
cured chronic streptococcal infection in rabbits, and t.avor�blf 
in
f
luenced the course or staphylococcal infections in r.abbitsJ 
but that the drug n.a without effect in the treatment of certain 
. .  '-..___, 
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pneumococcal and other experimental infections11 (B-5). The data 
of the experiments is as follows: Twelve mice were given a single 
oral administration of prontosil of' 0.,.02 to 10 mgm. The Eice 
were injected intrap,&ritoneally with 10 M.L.D. of ha>.molytic 
streptococci.,. Smears of' the peritoneal content of the control 
mice snowed large numbers of cocci as well as degenerating whit� 
blood ct1ils. Smears .from the treated animals showed no cocci or 
damaged ce�ls, but only & .few leukocytes, monocytes, or lympho­
cytes, � these appeared to be in good condition (B-7). 
Since this startling report, workers in France, EnglallQ., 
Germany, and t:ne United States have led the field of investip,tion .. 
Many ,of these workers have advanced theories to explain the 
mechanism of the bacteriostatic action of the sulfonamide druga..( 
These will. be taken up individWill.y latiir in the paper. 
, '-.. ,;_·, �-� 
:-.- '-�' 
.��-��-�;i 
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GENER.AL: OBSERV:!T IONS 
Tho laboratory investig.ations and the specific theories as 
to the mechanism of the -action of the drug have their bases on 
the c1inical -arii laboratory investig&.tions occurring shortly 
.tter the -advent or Domagk' s announcement., These miscellaneous 
observ.ations will be reviewed so as to .act as .a background for 
the specific theories, :a.nd to help correla.te these theories. 
The or1gi.n8.l experiment of Domagk was the use of •o.3 cc r4 
& l:10,000 dilution ot. ;a cu:l.t\ll.'8 of these organisms (bamolyti.c · 
streµtococcus), representing 10 M.,,L .. n .. • which was �ected into· 
the peritoneal ca•i ty of . mice.. •one :and one-hall' h<>u.1-s .d\ar 
infection, certain ot theae mice were t:i:·ea� or.a,lly with. d.of�S .  dt ··
Prontosil varying from 0..2 cc of• 0.-01 per cent aolu\ion to lA •41�·. 
ot .al per cent watery suspe�ion of the drug. The treat¢ mica 
.all survived seven days (the duration of the experiment.), wldle
the untreated controls ,all, died by the f'ourth day ot i;he inf eo� · 
(B-3). Thus, it was shown that the sulfonamide d.ruc w.s e&.J*o.lt,
of protecting the uimal from the f'atal effects of the halolytio 
streptococ-cus.. This experiment was otten repeated in nwnerolll 1
but now insignificant, investig�tions performed on the Continent.,_ 
am the results varif'ied the findings of Domagk. 
By plot.ting the growth curve or his experiment ap.:i:ii�'\i,; 
.sta:nc:h.rd growth eui'fi wt the bamol.ytic streptococci .a  set 
forth by Zinsser, Marshall. found the following res t (B-1h 
.: . - .. '.,.,�> - ::� . ... , ... ·-.,·. 
. .- }_ .. :,, 
·£, 
·� ; .. ·.-.. ".;_��;
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Thus it is shown that, al.though the drug has a very marked .at.fact 
on. tba growth curve, there is• lag period o£ several hours before 
the dist&vor.a.b.l.e effect ls .wanit'ested. ..After performing sevei·al. 
experiments on the growth curve, Spring came to this conclusion, 
•The principal feature exhibited in all the growth curves was
tb&t multiplication of the bacteria in the presence ot sulf'a­
pyridi?l8 W&S esseutia.1 before any bacteriostatic or bactericidal. 
.action or the drug became evident• (74). His observations were;
•The various growth curves indicate that, under the conditions
ot these experiments, growth of pneumococci occurred in the 
presence ot concentrations of sulf'apyridine up to 10 mgm. per 









sul.f',apyridine, for an initial period of 4 hours or longer .,
During this early veriod there w-as usually no appreciable lag 
phase alXi the same logarithmic rate of growth occurred with 
sulf'apyridine as without it .. The growth phase was usu.ally 
f'ollo,red by• phase of' stationary growth and then a period or 
maximum su.lfapyridine effect• (74)., Clinical observations 
substantiate this observations where it bas been noted that the 
drop in a feb*ile temperature and clinical improvement of the 
pe.tient does not take place until after a varying period, on 
the .average ot £our to six hours. 
Why does not the effect become manifest immediately? 
Mellon puts :forth the answer when he �ys, 11sulfani1amide 1 -as 
it .is f'ashio.ned. in the l.a.boratory oi' the chemist, is as harmless 
to bacteria .as sugar of milk were it not for the c&pacity that 
it posse6ses to be oxidized to the •activated'ff form by the 
bacteria themsel.ves.. Thus their growth is impeded, or as we 
say, bacteriosuitic. Obviousl.y, it means that the awerobio 
infection would not be so likely to be overcome as rerobic onesw
(56), Discussion of his idea will be presented in a later section, 
The next question to come up is just what is it that is 
happening to the bacteria to show a decrease in the �ate o£ the 
growth-curve .. Ball.enger .and his co-workers state, •When sulf',anil,­
c&mide is diluted as much as it is in tbe bl.ood stream, in vitro 
it &p:peers to act as • bacteriostatic rather than as &' bacteri­
cidal •gent, The investigations .... .., •• imioate that sulf'-anW.m:We 
-6-
acts in vivo by bringing about a change in the susceptible 
micro-organisms, which permits phagocytosis� (3). •The results 
o£ these in vitro experiments suggest tnat su.lf'anilrunide even in 
a concentration as high as 1% is prim&rily bacteristatic and 
only indirectly bactericidal toward ha?molytic streptococci of 
groups cA and D", remarks Neter (61). Bliss found also that there 
was no direct bactericid.aJ. action on h.emolytic streptococci (7) .. 
Osgocxi says that his experiments show conclusively that even hijh 
concentrations oC sulf�.nilam.id@ does not kill the beta hamolytio 
streptococci (62). Spink agrees that the primtty action. oC the 
drugs is one o£ bacteriostasis, and£ound t�t there is a dimbt.1-
ti.on o£. the r.ate o£ growth o£ the bacterial cells (B-4}. Bliss 
used Welch bacillus &nd £01..UJd that the leukocytes were filled 
with ingested organislllS; the animals traated with ault.anilamide 
showed s. decrease of' bacilli £ree in the pE;ritoneal exudate 
� the leukocytes showed £ewer ingested cells (7}. He said, 
•the only interpretation that can be placed on the ooserved facts
is that sultanilamide inhibited the growth of the bacteria in 
vivott (7}. · Further experiments by Marshall led him to the 
conclusion, •There is othbr evidence to support this general 
view of the mi.ture of sull'.ani�mide ba.cteriostasis. It is the 
f'&ct that the process is readily reversible. ..ls any point short 
of complete bacterial death the organism will regain £ull 
-7-
mediUD1• (B-1)... Schnitker .also came to the conclusion that 
action WRS that of bacteriostasis (B-6); arxi so did Keefer (55). 
Thus it can readily be seen that the leading investigators of 
the drug have univers a.lly come to the conclusion that the 
primary action of the drug is that of ba.cteriostasis in the 
blood stream .. 
The general et'i'ectiveness of suli'aniJ.amide is a consideratlon 
of every clinioe1.l. use of the drug .. The general character and 
type of infection clinically shows a noticeable influence on th& 
efficacy of the medie&tion.. This has been ooncisel.y eiU!lllll8d by 
LoQaood thus, flThe clinical aspects of this study showed 
stri:k ing differell).ces in the ef'fectiveness of suJ.tani�mide • 
These differences were related more to the character Qt the leiion 
than to the identtty of the bacterial. infection. Sult.a.nil.amide 
was moet ei'£ectiv� in bacteremia, l.ymphangitis, erysipel.is, ,and 
cellul.itis; it 'A$ highly effective in early· iDfections with 
little suppuratio�. It had a questionable eff'ect in searlet 
£ever, tonsilliti$, sinusitis, otitis and mastoiditis. The 
drug was ineffective when .abscesses were well established, 
except perhaps injllmiting their i'urther spread and proteetilli 
tissues -against invuion when dr&illa&e aa 
tonsillitis bas later �en £own to 'be s�p,-. 
tible to sulf'�U.1,;,11- �iM,e, Longco}le (44) conclmea, •tna.t the 
-8-
over consider.able periods of time will not always eliminate 
hamolytic streptococci rrom persistent and latent infections 
of the tonsils:a ., •The number of badteria and the virulence of 
the strain are important :factors in this a�tion. Experimentally, 
the et.t'ect of sult,anj lamide is not evident if large inocul&of 
the organism .re usedu • .-In the llUJDan patient ...... when the 
infection exceeds• certain number of organisms, the ther.apeutic 
effects of sulf'-anUamide rapidly diminish, regardless of the 
virulence of the strain,* summeriaes Schnitker (B-6). In their 
experiments with p-ontosil and sult;anilam:lde, Long ,am Bliss 
.town that (l.} ciowa of harmol.ytio streptococcus or more than 
10,000 M .. L.D .. were .t'atal to their mice even though protected 
with the drugs, .am, (2), the.� streptococci of l.ow virulence, even 
onq one lethal. dose, was £.atal to the mice inspite of the 
drug protection (
B
-5)., King states that the ettect varies 
im'ersely with the number of bacteria (56) .. Neter backs up the 
in . vivo concl.usions with his in vitro experiments-1' sulf'.aniluwle 
in.a concentration of 1% £.ailed to inhibit visible growth of 
the hamol.ytic enterococcus, when undiluted broth culture was 
used for inocUlation of the test culture medium•. With smaller 
inocula, however, • marked bacterioatatic �t"ect could be 
demonstrated,,.� •• These observations on the relationship between 
the degree of. bacteriost.atic effectiveness of aulf-anilamide aDd 
tbl nuaber oC micrQ-Or��iSllls. used t"or iDocula:�ion �l 
[ - - _\_,/
those obtained with hanolytic streptococci and other bacter:La" 
( 60).,. The above writers have thus shown thb.t there are two 
factors which play an important part in the effective action ot
the drug-(1) the sue pf the inoculum, and (2) the virulence 
of the infecting organism. Clinically, the drug is effective 
in those infections where the inoculum has not had a chance to 
become too large, am in those infections which:are more virulent 
and produce more wide-spread infections rather than forming 
localized infections, 
Th� la.ck of eftioacy in looa.lized infections is the founda­
tion ot the theory at Lockwood .m his co-investigators, a�. wUJ, 
be taken up separately later. 
"'The blood taken immediately af'ter injection (ot s� · 
&mide) has a greatly encha.nced antistreptococcal power .... � .. ..A 
result of this kind izxiicates that the sul.fanilamide acts on the 
bacteria. without having to. be changed into some other .active 
substance in the bodyt', states Fl.eming (19) ! However I this doea 
not ..agree with the £iniings, as mentioned bet ore, by Long and 
Bliss. Fleming I s concl.usion f'rom his �.xperiment c&re open to 
·questioning bec&use his technic was not exactini .. Keefer
counters with, •we-were unable to demonstr-ate a bactericidal
effect of sulf'.ani1amide when it was .a.dded to plasrns, .althouah·
bacteriostasis wu pz-esent in plasma containing sult&ni�mide.
This ba.cteriostasis was less striking in plasma than it was in
I 
t, 
..... _. -_ __ .,;,"' -
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whole blood� ( 55),, Typical of the blood findings is that of 
Henschel�11 the number of guinea pig leukocytes taking up bac�eria 
and the number.or bacteria engulfed per leukocyte was marked.ly 
increased• (in the presence of sulfa.nil.amide) (27) .. The actual 
�feet on phagocytosis will be discussed later. 
Su.lt·an:U.&wide has been tried on every infection that imagi­
nation could deem its worth. It has worked in some diseases, but 
not in others. "Virtually all -Of the infections decisively 
influenced. are of zrobic nature. Ji.n exception is the st6.phylo­
coccus, which, however, is prone to form localized abscesses 
even when the infection is generalized" {57) F states Mellon. 
By tnis observ.ation he claims that his orlwil.tive-enzymatic 
theory is supported; this will be referred to .later. Broh-Kahn 
.f'ound that the org.,nisms which are affected by su1£an1la.mide 
dev�1op better m·obioally; th.it there· is bacteriostasis with the 
drug urner £r'obic but not under allall'obic conditions. From this 
he concludes that the drug at'fects only a:;robic mechanisms of 
nutrition, aoo. that al:lmrobic mechanisms are not .9.ffected (lo}. 
The consensus is tnus: the.t the sulfonamide drugs are eftective 
in zrobic infections. .Although the drug bas been found to work 
in some of the anzrobic infectiollS, each of such observations has 
been carried on under conditions where the media were actually 
arobic • 




in nature, but f'rom their maze can be reamed supports for the 
. . 
' 
various theories which will be breught to attention later. King 
has fouai that in tissue culture there is toUl'.li .a decrease in 
the size of the colo�, and also a decrease in the size of the 
. hmmolytic zone of the hamol.ytic streptococci (56). Lyon hli.s 
shown that streptococci grown in media containing sulf'anilamide 
became s'W!ceptibl.e to phagocytosis .fUXl .agglutination, but 
regain their virulence it tr.ansplanted back to a medium f'ree 
al the drug ( 45), flThe t'tilure of par.a...aminobenzenesulf oDDid.• 
to exvt-.a bacteriostatic effect upon group D e.nd minute members 
or group G beta bamol.ytic streptoc.occi in vitro is ot both 
theoretical ,&Di pr.ctioal importance,, T� resul. ts of the in 
vitro tests show that marked bacteriostatic e£tects were obtained 
when various str.a.ins belonging to group J., C, .and the larger of 
group G were tested. The significance or the variations in the 
various groups or beta bmmofytic streptococci is not clear, 
but it suggests that group D and the minute members o£ group G 
hamol.ytic �treptococci ..possess certain chemioal. or metabolic 
qualities which d�er .from those of the other groups ot hamo­
}3tic strei)toeocci•, .found Bliss (8}� From these statfitmenta we 
gleu two id•s-(l.) tbat the action of the drug ia on the 
bacteria and is reversible, .aDd (2) that there ia what saema to be 
• cl:limical (or ensyatic) 'Variation of the b&ctei·i.a which oaus••. ·






Bacteriology;attaches great :importance to the. appean.nce 
of the bacteria colonies in the degree or virulence. ·Tunnicliff' 
has foUDd, •streptococci :am pneumococci grown in 1:1000 sulfa.­
pyridine plain broth show by chain formation &nd staphylococci 
by slight colony change some� dissociation which makes the 
organism more pbagocytable than:anequal number in the S phase•. 
(76)., "When, to• suspension or vi.able bacteria susceptible 
to the .action o£ · aultan1 lemide, the drug is -added in sutf'icient 
concentr-:ation, the morphology of the bacteria undergoes changes 
-.tter seveital houra ....... The pieomorphisa illdioates degeneration 
. . . 
-:anri inJury of the cell•, is the results of .the work ot Spink (B-4) ..
Baclley town that serial passage of pneU11ococei through sultuil,.. 
illlide m:-oth lef't s� colonies with their original virule�, 
.am some cbanged from the mucoid to the smooth forms (25).. He 
-also says, •There can be no dissociation without bacterial.
growt-h :am multiplioation., Thus .a weak bacterioatasi1, taaintaillllCl
over a sutt'icient period, may f'-avor phase tr.ansf'or•tion, while
·&. strong bacteriostasis may prevent it• (25). Had.1-y cQUCl\lliea,
•.that the , sGlective' intluence of su.1.tanilamide on the more
virulent mucoid, .and its diminished inf'luence on the less viru:,..
lent &lllOOt,h, might help to explain the greater .observed. thera-1
:;,eutic eft'ects of this drug in patients experiencing severe
streptococoal inf'ections than w.ben;administered to patients





f.act in these expressions is that there is a change in the 
colonies of the bacteria from the more virulent £orm to the less 
virulent form, brought a.bout by the influence ·ot the su.lfanila­
mide upon the bacteria.,.
•conceiv.bly, bacteriostasis may come about either-through
the inhibition of the growth energy o£ the organisms, or its 
r�direction toward th,e evoiution o£ a leas virulent and more 
pbagocytable growth phase•, states Mellon (B-7). He goes on 
testate that his co...-orker, Locke, •suggests that bacteriostatic 
• c 
:action is in some instances .associated with-a trend toward• 
emooth or non-virulent phase" This change need not imply a 
·reduction in growth energy, except in so tar as it conduces to
phaucytosis, which event ul.timately results in an .almost complete
supression of growth" (B-7)" From this, Mellon would seem to
imply that the eff'ect ot the drug on the orsa_nism is not directlg·
on: the phase of the organism, but rather that ther'i'.,; bas taken
J.1.a.ce-a cha:nge which is manif'est in the change in th9 phase�
. . . 
There a.re two. statements which show the associated factors 
in the eff'ioacy of the sulfonamide drugs which do not need 
substantiation because or their universal .acceptance and approva1 
by .all investigators .. Bush states, "In gener.al, the drug ia 
more effective the higher its concentration, the higher the 
te�ture, the tmaller the number ot organisms, and the poorer 
the mediwa• ·(12) ._ Collin suu up his ,article by saying, •that·
1"· · .
-1.4-
the presence of &ntibody ·and sulfanilamide was much more etf'ective 
than either of these· ;agents alone. From a practica.l stam.point 
in thera.peutics, it has been f'ound that a patient who posnsses 
antibody £or .a spec.ific infection derives much more improvement 
than: one who bas little or no antibody formation" (15). Schnitker 
is also of the same opinion as:he states, "the body must retain 
or .acquire an 1.mmWlity to rid itself of the ;arrested organisms 
which .ar-e producing the .disease• (B-6}. 
The clinical experience has been SUJ.lllled by Keeter as� 1Tro11 
the experimental ,as well. •s t_he cllnical evidenQe so tar we a.re "t 
forced to concl.ude that at least two con:iitions are essential 
tor� optimum theapeutic .action or sult'�ide. The 
chemical must be present in suft"icient coneentr�tion to prCld�• 
opti.mwrl. baeteriostasis, &nd the body's ii1id'ense mecbani•m must t<: 
.acquize or retain the power to destroy viable organisms• (SS) • 
. In &"WIIDiU"f, the main points tbat have been shown here ue: 
(1). sw.f'•nilaa:uie prod:uces -a bacte;dosta.tic actl.on on the p-QW'th 
of the organisms .Uected; (2) there is a lag in_ the aotionJ 
(�) the diseases .af't'ected are those of arobic nature and where 
the Ol"ganisms ara not 1.o�ed in an .abscesea, and (4) the eff'eats 
noticed.bacteriologioally irxiicate that the ettect u d:1.rect,q 
on the bacteria, ii) some way at'feotiDg its metabolism, as shown 
by 1;be change in phase -&Di decreased. vii,-ulence. 
-15-
JLQTION ON THE BODY DEFbNCES 
,Although.it has already been stated that. the action of 
sulf'ani.la..dde and its derivatives appears to act directly upon 
the organism, ti:ds point-the action· on the defe�se system 
of the body-needs further discussion.. The problem of the action 
has been approached from various angles, and it seems to resolv.t 
itself' into three main issues: (1) Do these drugs act on the 
org�nisms simply as chemical disinfectants'l (2) Do they exert 
a stimula.ting eet·�ct upon the natural body defense mechanisms? 
(3) Is their activity the resul.t ot a combination of these two
ef'.tects? 
The theories that have been proposed to -answer these 
questions may also be divided into three maln groups& (l)·that 
the drugs have• stimulating ,action on the specific and non­
specit"ic body daf'enses; (2) that the drugs neutralize toxic 
bacterial products; and ( 5) tba t the drugs act on the bacteria 
themselves, either as germicides or in some way to prevent 
inv.asive power or ,ability or the organisms to multiply .. 
The £irst group of theories center themselves around the 
bl.ood, aoo more specifically the antibodies and the problem of 
pha.gocytosis by the leukocytes. Early in the investigations, 
Mellon expressed, :"The £requentl.y observed lack of the drugs 1 
bacterlostatic action . ...n vitro, in contrast to their effective­
ness in vivo, suggested the exp.la.nation that their action might 
- -
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be -associated with the presence or the blood• (B-7) � Schnitker 
f'ound that when tested in-a 50 per cent normal horse serum brotn, 
a concentr.ation o£ 'sulf'a.niJ.a,a.ide showed lil&I'ked bacturiostatic 
action, whereas his experiments in plain broth r�quired much 
higher concentrations (B-6),. Mellon l&ter in his book_ says, 
"that the blocp serum has its normal inhibiting and killing 
power £or stre9tococci enormoLlSly enhanced, &1ld this by rel-
-&tivel3 minute concentr-ations of the drug in the blood• (a...;7) • 
. As -.a resul.t, it oan be seen that the bl.ood is the :active vehicie 
in the c;,urying ot the drug to tbe bacteria. These timin&s 
� the basis tor :&d,-ancing the tbeories of enhancemeJJ:1;; - of 
! 
�gocytosia ;Gd -anti-toxin '8..Ction. 
Somewhere in the earl.y liter.ature on the -action of the 
s�OJ'.Mlroide drugs there was proposed the theory that the e.ction 
I 
, 
... due to the stimulation ot the body clet"ences, e. i• anti.... 
bclJdies and phagocytoais. There has not been very much written 
� the affirmative eide, but quite a bit 9n-the negative aide 
I 
has been Finted .. The observation that whole human blood is 
more oa.ctericidal. than blood from which 80% ot the leukocytea 
have been removed, but containing the same concentration of 
auleanilamide (lil0,000) led to the suggestion that the leukocyw 
enhanced the killing action of the drug, &Di vioa �Nii (B-7). 
•Just how s�e enhances plagocytoaia 1$ not clear, but .
O\U' results brief.'ly reported � suggest- . that sulf'en1 lami4e
' \.,_.,,:. 
-17-
or a serum-sulranilamide comJ;llex acts a.s an opeonin", is the 
report of Fenk:elstein (18). Tunnicliff agrees with the phago­
cytic theory �s a result of his experiments with the cocci 
groups, stating that the drug stimul.a.tes the activity of leuko­
cytes, but does not act as opsonin (76)., .Alyea admits that there 
is.a possibility that the drug may increase th1;; phagocytic 
power of too white cells (2) .. 
Because this suggestion h&.s been advanced, it must bb dealt 
with so as to locate ,as accurately as possible the action of 
sulf.anila.mide,. In the large, the majority of the materi.al 
printed has been in the nature of proving that such is not the 
explanation of the action of the drugs. "The probabl.e exp-1,ana ... 
tion, however, is that sulf'anil.am.i.de in concentrated soiutions, 
like so many non�specitic comouods is somewhat toxic for leuko­
cytes.as well as bacteria but in dilute solutions is toxic only 
£or the organisms.. Such an explanation wou.ld iniicate that the 
ef£ect of sulf'anilamide on phagocytosis is not a fundamental 
one and therefore does not explain its mode o£ aotionn , is the 
opinion expressed by Chandler (15). Ballenger is of the opinion 
that the drug holds the organism in check until the body defences 
are ,able to conquer the disease (�).. t1In th� cUl'rent literatUJ'a 
one £1Dds some indirect evidence which might .tend to support 
the concept that su.ltanilamide .acts through promotion at plago­
cytosis •nd stimulation ot body immunity. That pbagocytosia . 
. ! 
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does not ex.plain adequately the phenomenon is evident from the 
t'act that normal serum, from which the leukocytes· have been 
removed, is »st .as et£ective a vehicle .as whole blood f'or the 
action of su.U'.anilulide on streptococci•, concludes Schnitker 
in his ev.aluation at the problem (B-6). This statement counters 
the pu'bli�hing of earlier writers. 
Mellon counters this.theory o£ pbagocytosis by saying, 
•�though our experiments do not conclusively rule out a. direct
effect of the drug on phagocytic mobilization, there 1a notbini 
in them to indicate that it occurs, In f';act, there is no c� 
,.l.lini reason £or iavoking it, because the ur;questionable 
bacteriostatic effect of the drug in vivo is probably sutticient 
to redicate • cessation in the production of negativel7 chemo­
tactic substances by the organisms; and this in itself may be 
considered a decisive £actor in the mobilisation ot the 
phagocytes r The cell dominant in the proces�. appears to be
determined. in f'act by the degree of virulence and the-a.s04µ,at.ecl 
cbemioalattributes or the strain in question• (B-7)4 .He had 
uso £own that sulf'.an:Ji.mide t�py did not alter the qualita­
tive character of the cell or tissue response to the •· strepto­
coccua (B-7}. Mellon;anp his cQ-Work:ers conclude, •The weight 
o:t evidence :at present does not SUP})Ort the view that the drua 
baa .a direct inf'luence on the ao'biliaat.ion or increafe<i proclue�ion 
� either type ot pllagocyte •t their source. Nor ia :tbere 




of individual. l.eukocyte, once it is mobilized at the site ot 
injury., It seems reasonably clear however, that the drug in 
no� inJur&s the phagocytes so .as to prevent their ingestion 
ot. suece.Ptible micro-organisms'• (B-7) .. · Professor F. P. Gay,· 
in a personal communication to Mellon summarized the resul.ts 
or his work by stating, "sullanilamide apparent11 produces• 
bacteriostasis sufficiently marked to protect the •ccumulated 
leukocytes -and to allow the na:tun.l defense macrophages to 
'8.ccumulate.. There is direct evidence that t.be d�ug does not 
in itself' staw.te the mopili&ation of the acro:pbages• (B-7).
�tis of the opinion that,.in the a..se of pneumon:a, 
up to the crisis sul.t•p,r4dina produces a. rapid decrease :in 
1-llltocytes (1)., Britton took white blood counts Zrom 50 pa�ta . 
i 
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Sttliying the reticulo-endothelial system, ·which includes 
the phagocytic cells, �one came to .the conclusion, •Sultanilam:Jde 
therapy does not alter the cytol.ogic response to intection in 
exj*rimentu. ,animals"' (45}. McIntosh al.so concl.udes that the 
drug does not act -as a simple l.eukocytic stimulent (46h or·
the same opinion is Whitby (80). Bush also· studied the reticulo-, 
endothelial system and f'ound that Uie drug does not alter the 
leukocyte pattern of the b1ood or ot�r tissues, :am that. the 
drug .acted solely to inhibit the growth of the micro...orp.nisms (lit} .. 
In usi.Jl& the bl.ood ot patients taking sul:t•Pfl'i4i•, 
Pleming concludes tbat the ettieiencyof the l.ellkocytes is uot 
inCN&sed (20)., By doin& blood counts on patients re oeivinc tQS· 
drug, Bigler .found that there wa.s not produced .an� in 
• .L 
the total leukocytea or in the proportion ot the polymorpho-
nucle&r cells (5)., •It seems unlike}¥ from these experiunta 
i;bat the ther--.�utic &ction ot these drugs is dwt to ..an inoreaaed 
chemot.ropism ot �ucl.ear leukoeytes•, is expresaecl 111· 
C.an (l.6) .. The weight of evidence, thus, is apinst a atia\wr 
latiDg or mobilizing effect on the leukocytes. 
SchnitQJ:' 1 s concl.usion&s regards pha.&ocytoeis is, •SUlt.a­
n:ilam:ide does not. stimulate the defense mechanisms o£ the hos't
in .any appreciable degree ..._. • .,In £.act experiaumts imi.oate that 
\be sulf,&n1Jamide COlllJO•� are F&Ctioally uaele iis 1D those 
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other words the sull ..anilrunide inhibits the growth of organisms 
and prevents overwhelming intoxication until the defense mechan­
ism of the body; immunity, can be mobilized and finally bring 
about recovery (B-6). Dr., Gunderson, be.fore a faculty meeting, 
stated that sulfanil.l:mide does not arouse a specific response 
on the part or the host, and that there is no direct ef'fect on 
phe.gocytic activity (77) .. 
Although there has been no :authors -advancing the idea that 
antibodies were stimulated through the use or the sulfonamide 
·drugs, several authors have investigated this possibility.
l 
McIntosh reports that the drugs have no stimulating action on
the body defenses, nor does such administration .affect the
quality, quantity or speed o£ production of recognized specitie
,antibodies ( 46); Spink is or the same opinion (B-4} ,
The f'oregoing statemeds have dealt with the problem of ;a� 
stimulating effect or the sulfonamide drugs on the body defences. 
There -ere a £ew men who have advanced. am supported this theory, 
�nd these were in the early days a£ the drug' a history.. We 
find, however, that the preponderance of evidence is ot a-�g­
ative nature. There has been found to be .actuall7 a leucopenia 
during the use of the drug. Most of the writer suggest that 
adverse conditions :are decreased and this permits the leukocytes 
to tultill their function normally. Thus, the weight ot. the 
evidence is .a-inst the stimulation of the body defenses, either 
. 
, 
'by pbagocytosis or ,antibodies, and this possibility- is ruled out., 
··:---,, 
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ACTION ON BACTERIAL TOXINS 
In examining the action of every drug used in medical 
practice
� 
it is logical to investigate i� three possib
. 
ilities-­
stimulation o£ body def'enses, action .ag inst t.tle bacteri.al 
toxic products, and act;ion directly on the bacte:ri.al toxic. 
products, and action directly on the bacteria itself. Attention 
is now turned to the second o£ these problems. For the sake or
sim.plici ty in handling, tll or th� various toxins will be
considered •s ,a unit. 
During the time that Doma.gk was experimenting in Germany, 
word ot· his experiments was obtained by some of the other 
scientists, Levaditi aIXl Vaisman a.re reported by Goss to have 
announced in 1935 that they found that prontosil'8.ppeared to 
limit streptococcal hemol.ysis and leukocidin; thus concluding 
that certain sulfonamide compourxis exert an antitoxin .action 
(24)., This idea has been f'ollowed by Osgood, who is its main 
proponent in this country. .ls the resuLts of nis experiments, 
he reports, •The major action of sulfanilamide on the beta 
haemolytic streptococcus seems to be neutr�lization of the 
toxins .. Either beoa.µse o£ this action, or incidentally, it also 
decreases'the rate of cell divis�on o£ these organisms. It 
ap:vea'rs not to kill these organisms directly, although it does 
permit the bactericida ... properties o£ human serum and to some 
extent phagocytosis by leukocytes to kill organisms which they 
otherwise would be unable to kill* It has no direct effect on 
I 
l. 
phagocytosis·" ( 62); he continues to the effect tba t the increased 
· phagocytosis is due to the neutralization of the bacterial
toxins by su.lf'anilamide and that the drug has no direct effect
on either the l.eukocytes or bacteria {ibid). .After having
been severely criticized for his report, Osgood returns with,
·"We -are still at the opi�ion that the major factor o£ sult•nil­
&iilide is on the tocins or aggressins• ( 63) • 
.Although Osgood ravors the :action onthe toxins themselves, 
other workers believe the action to be on the production of 
the toxins; this idea ties up to some degree with the .action 
dlrectly on the cell, to be treated. in the next section. Gay 
concludes that the action is upon the coccus not on1y by� 
iting growth, but by a temporary inhibition ot b.emotoxin forma­
tion; the drug does not neutr.alize hemotoxin already f'ormed (25), 
The experiments<;)£ Bayl.iss, "lead one to believe that the only 
manner in which the toxicity of staphyl.ococci is .affected is 
by an inpibiition of growth of' the organism with a consequent 
decra..se production o£ toxin• ( 4) - Bush -also believes that 
there is .an inhibition or the production of toxins since test 
-.aniilials are not . protected t;#rom tht: toxins of various bacteria 
in which the drug is ef'£ective by the use of the drug (12). 
King does not believe that the toxin production is dire�tl.y 
..rfected,·.basing his opinion on the !&ct that it the drug 
neutr.al.iaed hemolysis o:r reduced the formation of hemol7sin 
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out of proportion to the reduction in the numbers of organisms, 
the h�molytic index of experimental colonies would be lov1er. 
He did not find this to be the case, a.nd concludes t�t such a 
reduction in hemolysis as is observed is secondary to the 
bacteriostatic effect of the drug (56). Schnitker believes, 
1"The experimental evidtmce .avail.able at the presi;::nt time does 
not appear to be sufficient to conclude that an inhibition of 
toxin formation could be the adjunct f8.ctor supplied by su1£.a­
nilan1ide in the anti-bacterial mechanisms observed in its chinica.l 
use• (B-6). Osgood likewise does not believe that there is an 
.a.f';tect on the toxin-pt"oducing :ability o£ the bacteria {6�). 
Inspite of his opinion in one articl.e, Osgood reports in 
another artilele that suli"ani�de does not inactivate in vitro 
significant -amounts of hemotoxins of the beta hamolytic streP­
tococci 1a.Dd others; and says that the sulf'anil.amide ther..apy did 
not significantly at£ec� the course of int�tio;n in guinea 
pigs (64), When testing ha:mo1ytic streptococci on blood .agar 
plates, Kem:v could f'im no dirt"erence in the -anti-hemolytic 
effect of the co.ntrol and sulf'anilamide plates (55). He also 
found that injections of streptococcal toxins plus sulfa.nilamide 
(l:1000) used in the Dick tests, showed no ditference from the 
·controls; since antitoxins neutral.ize toxins, he concluded there
•s no .antd.toxin effect (55),, By using the Shwartzman phenon,..... 
enon, Schneierson f'o'UJld that the sulf'onamide drugs ha.ve no 
effect on the in vivo action of the toxins already formed-betQ%'-;1 
• 
cell death (69)., Buntington rs experiments showed that, •Sulfa ... 
nil&mide produced .a slight•dela,y in hemol.ysis in blood-broth 
cul.ture of hanolytic streptococci., This effect was probably 
.attributable. to modii'ic&tion of the· growth""'°urve. When used in 
concentr.ations equal to or greater tnan that induced in the 
body f'luids.ther&peutieally, sul.f.anilamide waa without,.pparent 
effect upon tibrinol.ysis or formation of erythrogenic toxin 
in vitro, and n.s una.ble to inactivate small .amounts ot toxin• 
(30) .. In criticiaing Osgood, Helmnens states, •the •uthor•s
results do not suPPQrt their concl.uaions that the pri.JD.nr•ctioa 
. ot sulf'anila:mid• is ..a neu,t:.N.l:iaation ot tC>rln in the °*" �
the be-ta etnptocoecus• {ts),. ling believes that the reciuc�- ·· 
. 
. 
in the �iae or the hemoJ.Ttic zone on culture plates is di.18 to 
the baeterioatasis which causes ,a reduction in the s:L.not-tbe 
colony (S6)., •There is no e"rl.dence that the drug neut.Nl�•• 
bemo�sin or reduces its formation beyond what oan-1- -account.� 
tor on the baaia. o£ .a reduced number of organiam& involftd.1' Cild4)* · 
I 
• • • 
• 
' • 
· In working on mastitis, Bauer .no: Gum.erson conclude tha:\i, •the
c1rug·, s role is one pri.:maril1" of bacteriosta.sis, .allowing ·tbe
bodily defense mechanisms to catch up with the invader•" (77).
The -.i-Uer uperiments show that with the use of the 
sulto,a.mide drugs that there is ,a decz-eaae in the .uount a( 
toxins frOJ11 the bacteria,, 8"er-al authors state that tbf. 
action ot the drug is by dµ'ect .· ,antitoxin ettectt but t�t 4Y,ISO 
I_ 
indicate that the phenomenon can be indirectly caused, vi:a the 
bacteri.&.. However, the we�ght or the evidence is against the 
.action being directly on the toxins from the bacteria. The 
reduction o£ the to.xins, however, is not denyed� From this we 
oa.n conclude that the drugs produce a decrease in the .amount 
or the toxins released in the body, but that this reduction is 
secondary to the primary e££ect of' bacteriostasis on the bacteria .. 
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ACTION DIRECTLY ON THE BAC1'1:J:U.A. 
{ I.. CHEi.USTRY 
The third possibility of' the action of the sulfonamide dt-ugs 
in the treatment of diseases is the action of the drugs on the 
bacteria themselves. First will be presented the chemistry of 
the drug, and then the various theories which have as part ot
their expianation the chemistry of sulfanilamide. 
The .axo dye, .known as prontosil, has the following struct­
ural. formula: 
*Most investig.tors now .,agree that the activity of the ·UO
compounds is not directly associated with the azo structure, but 
with the paI11L-o&minobenzene-eulfonamide•, asserte Mellon (B-7) ,,
. Jls bas been mentioned, the dye is broken down in the body and 
the .active jll'incipal. is p,,,,,aminopbenzene-sulfoDamide, which has 
the following f'ormula: 
Since it is known that the benzene ring is not of therapeutic 
importance in the body, it" must be the radicals which are attached 
to i�he amino and t� sul.f'onamide groups. Various investi­




.attached t:i:lenpeutic importance, am to ex.i.lain the action of 
_the drug on the basis of the chemical radical involved. · 
The sulfur of the sulfonamide group has been replaced by 
such elements •s e.rseni<::, carbon am phosphorus and the compounds 
.found to be therapeutically active. Hence, conclude Rosental 
and Bauer, the sulfur is not essential to activity against 
. . 
bacterial invasion; "'however, it is true that the only compounds 
used to any extent, or which have demonstrated outstanding 
ther.apeutic value, do retain the sulfur in the sulf'one group, 
para to the udno group" (50). Thus the sulfur is not -absolutel.y 
essential, but is relatively important. Maher states, :t1The 
.amino group ,aDd the sulf.mido group ,;mus1; ;be:_ ln :_the:�c'J)llr&f 
position on the benzene ring-par.allel compounds with these
groups in the meta or ortho positions have shown little or no 
activity therapeutically• (50). Marshall has touoo that, "little 
or no activity is t'ound in mononuclear compounds in which eithar 
the -amino grou!,) is replaced by some other group or the sulf�na.:llid.e 
. ! 
group by groups not yielding -a sulfonic acid on exidation •• � •• � 
I 
a shift of the amino group to th� ortho or met:a position reekits 
·1
in loss o:f activity; also a thir<;i group in the benzene ring 
! 
I 
He, however , 1 results in loss or lowering of activity" (54). 
concludes, "the sulfonamide group is not necessary £or actiV!-
1 
ity• {54} .. On the other side, Mellon and his co-workers believe 
that the investig.ations o:f more recent date appear to connect 
I : 
the activity o:f the drug i.-i th th� p&ra-linked sulfur (B-7}. 
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Fr� these statements we find ,a gener.al agreement that the ortha 
position is necessary; that the amino group is necessary; but 
there is a difference or opinion as to the importance of the 
sulfone group. 
The �ino group is the most important, judging from the 
.amount or liter-ature printed referring to this group. Mellon 
is the leader or this set of experiments. In investigating the 
behavior of the ,ara-amino-benzene-sultonamide, he found the 
.following.com.pounds to be formed {56}: 
Reduction Oxi.da:tion 
< ) 
HNH HNH HNOH 
0< ·0< >0 �0






2. Hydrozylarn1ne deriv.ati.-e-i�rmedia.t.• oxi.dationJ 
•we have .already demonstrated that this derivative
is enzyme-poisoning in its effect, being �tic­
ularl.y..active against the ena:yme catalase•(56). 
5., Nitroso deri'�tive-oxi.ciiud hemoglobinJ :responeible
.for the toxic s�ems, but not responsible tor 
bacteriostatic :action., 
4. Reduction to thiophenol-is very toxic; shows
.! 
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capability of .anzrobic reduction. 
·s. JlcettJ: derivative-Cormed by action or liver; is
completely inacti?le because bl.ockage of� 
group prevents oxidation. 
Spink .agrees that the ,amino group situated in the para position 
of the ring is related to the ther..apeutic activity of the 
compounds; the -acetylated form, formed by the substitution of 
&n ac�tyl group for one of the hydrogens in the animo group, 
also shOlfs the importance of the animo group for this conjugated. 
form has no antibacterial activity. (B-4}. ;Another argument he 
uses is that other compounds w:i,th non-sulfur-containing groups 
opposite the para-6.lll.ino position of t�e ring also have -anti­
bacterial. action (ibid). Maher writes, •Removal of the uino 
group destroys the activity of sulf'anilamide, while blocking of 
the group, as occurs in the conjugation, greatly lessens 
thera_peutic val.ue with little reduction of toxicity" (50)., 
•Recent findings on another class of compounds", writes
Mellon, •have shown that the bydro..xyl,..amino group need not 
reside in the par.a position .. The sulf'ohydroxamides, which may 
be devoid oC .any para substituent, but which have a peri'ormed 
bydrwcyl...amino {Voup.attached to the sulf'ur atom, possesses 
definite a.nti-catalase properties and correspondingl.y strone 
bacteriostatic power� However, there is as yet no evidence that 
the cyroxamide group can be .formed from the amide group in 
vivo an:i hence in the c....se or sulfanilamide the the .activity 
must be referred to the para-e.mino groupl' (57). Shinn found 
' I 
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that experiments with para-caproylaminobenzenesulfonhydroxsmide, 
which contains a hydrwcy.l.amino group located differently in the 
molecw., was shown to be capable of initiating bacteriostasi.s 
in broth cultures oC the pneuinococcus without the degree of .J.ag 
manifest&d. by sul.fanilam:ide (82). . Shinn .also states, tiThe great 
volume of cl.inie&l. am experaental work carried out with sult.a­
nilamide compounds has shown that the presence of the sulfur 
group is essential to their effectiveness• (71}. Maher found 
that removal of the sulfonamide group leaves a highly toxic 
compo�, -�nine-of no value .al.ong ther.apeutic lines (50). 
'"Replacement ot the sulf'ona.mid.e radical by -amino, nitrll, 
sulfonic .acid, arsonic acid, or carboJcy"l radicals produc� inactive 
com»ounds•, is the findi� of Mellow (B-7). 
The clinical observation of the lag in the action ot the 
drug has been explained by several.authors, includi� Long, on 
the basis of a time element in the change in the chemical 
substances by oxidation.af'ter the� introduction into the 
:animal organism (43}. 
Studies ot the chemistry of sulf'•nilsmide thus show that 
both ·the amino .and the sul.tonam�e r.a.ice.ls play a part in the 
i 
bacteriostatic .action of the dz-Ui. The uino group, by weight 
ot evidence, seelll8 to be the :mor� important. The suU'onamide 
I 
r-11ca11a not so important,_butI substitution tests •hQw that
it is indispensable.· The .active
1 






ap�ars to be the intermediate oxidation derivative, f'or the 
l'zydroxamide radical is bacteriostatic without the lag period. 
This derivative f'its in with both the peptone and enzyme theory 
of action. The lag is explained on the time consumed in the 
I 
oxidizing of the -amino radical... The sulfonamide :Il&dioal appears 
to play an important part in a.narobic bacteriostasis. 
_,ACTION DIRECTLY ON 'filli BA.CTKRLl 
II. PE:PTONE THEORY
tevaditi was the f'irst to put f'orth the supposition that 
in some way the sulf'anila.mide attached itself' to the host's 
protein, .and in this manner remered the host unfit as nutritiv$ 
material for the inv..ding bacteria; this action, he explained, 
caused an arrest ot' bacterial multiplication, or by a blocking 
or I oapsulogenic potential••. The other possibilities which 
he suggested have been previously mentioned (B-7). 
Early in the days or sulfanih.mide, it was observed. that 
the drug was not effective in case of l.ocal.ized sites or inf'ection, 
such &s an .abscess. It was also f'ound that f'or this type ot
infection to be cleared up that drainage must be instituted ..and 
.all necrotic tissue possibl.e to be removed. Lockwood started 
his investigations after having made this observation, "t� 
presence of debris, human or bacterial, diminished thei effect­
I 
iveness of sulf•njlamide on the hamolytic streptococc�s. In 
each instance the org&nism remaining in broken down ti�sue .
maintained their virul.e.nce• (41.). One of his earl.y ex1,.ri-
• I 
ments in vitro showed that in large inocuJ.a, peptone •• pro-
duced by the death of some of the bacteria; thus he postulated 
that possibly the more resistant survivors gain pepton� in this 
manner (40). One of' L""Ckwoods later postulates was that the 
mode or action of su.lf'a.nilamide was either by acting o� substrate 
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to prevent the action of proteases, or by interfering with
activity of enzymes (40). · .Another iffvitro experiment showed, 
"The addition ot· small amounts of peptone to the serwu yields 
a nedium suitable for the active logarithmic multiplication of 
young streptococci. ,.A.t the same time, th� presence of peptone 
tends to prevent su.lfanilrunide from exercising the full effect 
of which it is capable in peptone-free serum• (40}. He suggested 
that sult'anila.mide prevents specialized metabolic cactivity by
prevention of the utilization of the protein substrate by the 
organisms (ibid). The addition of peptone to serum deficient 
in nitrogen which is easily assinti.lable by bacteria, bel.ieves 
Lockwood, supplies such&n excess oi� nitrogenous material that 
the bacteriostatic action of suli'anilaruide is to -a large degree 
inhibited (42) ., Other fi:ooings by Lockwood led him to say,. 
11 Normal human serum does contain minute quanitities of free 
amino aci.ds and other derivatives at protein catabolism. 
Since the organisms ths.t are know to be susceptible to sulf'a­
nilamide are not, in general, actively proteolytic, it is 
reasonable to suppose that when they are inoculated into blood 
serum they depend at least in part on obtaining assimilable 
nitrogen from protein metabolism rrom previously hydrolyaed 
protein. Since the concentration of such free. amino nitroien 
is rarely high, it is obvious that the addition of very small 
traces of pegtone may markedly al.ter the amount of .assimilable 
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nitrogen and thus signifioant1y improve the status of the 
serum �s a culture medium for non-proteolytic organisms, such 
as the hauolytic streptococcus. The'.fact that ef'f'ective 
sulf'anilamide •ction depen:ls on the exclusion of added peptone 
suggests immediately that the drug must act in some way through 
interference with the ability of the bacteria to utilize the 
tr.aces ot· assimilable nitrogen" (42). From the work or LockWood, 
we find that it is thought that sulfanilamide inter£ers with 
the metabolism of the bacteria; and that the -addition of peptone 
supplies an excess of .assimilable n.Ltrogenous material, thus 
nu.l.lit"ying the bacteriostatic action o£ the drug. 
J..bout 1958, Marshall, :a co-worker of Lock.wood, noticed 
that the pres�nce oC a small .amount o£ peptone, prepared by 
enzymatic digestion of casein or lean meat, would significantly 
diminish the bacteriostatic affect o£ su.lfanilamide ?n baolytic 
streptococci in hum.n serum (B-1} .. It is this type ot protein 
that is commonly used in the bacteriol.ogy laboratory to supp1y 
readily c&v.ailable nitrogen to types of bacteria which are not 
equipped with-active proteolytic enzymes with which to convert 
complex Fotein into utilizable amino acids; e.g., ha,molytic 
. streptococci, Marehal.l evaluates this phenomenon as evidence 
that sultanilamide tends to prevent the carrying out ot some 
nutritive process essential to bacteria, conjecturing that 
peptone -contains some petf�ed element which is essential to 
bacterial. growth, the utilization of which is_ blocked by sult•-
i 
I 
nilamide (B-1) .. 
Before following out the indications of Lockwood and Mar�hall., 
the .timings of concurrent workers should be mentioned so as to 
dove-tail all of the works. Spink' s conclu;s.ions trom his exper­
iments coincide with those of Locbood, viz., peptone inter-
feres with the bacteriostatic .action oC sulfa.nil.amide {75)(72}. 
He states.that in,abscesses, peptone-like substances are formed 
.a.s .a result of the brealaiown of protein material (75). Schnitker 
fourn that the normal bacteriostatic -action ot human blood 




Working on the £iming of Bainbridge-that some spec�, or bacteria 
are unable to break down protein molecules to obtain essential 
nitrogen.....Schnitker conJectured that sulf'anilamide interfercts 
with the f'ood suppl.y of the organisms, and that an excess of 
protein nulli£ied the action of the drug (�}. The report fr03 
ling sta:t.es, "i.Je have fQu?Jd that the presence o£ ,a small f'rae;-
ment of tissue in the tissue cultur� greatl.y .antaeoni.eea the 
ettects of sult.a.nilamide even at a considerable dist.a.pee from 
the i'ragment .., ..... . ..We believe that the products of tissue
disintegration exercise .a protective et.feet on the org.ani.sms• 
{56), 
The clinical observ.ations of Longcope was that the admin­
istn.tion of even capuativelt 1-rge uounts of sulfanilaJ1ti.de . . 
t:aµed always to eli!Jlinate hamolytic streptococci from pe.rsiat-
. ·' 
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ent cam latent infections of the tonsils (44). MacLeod f'ound 
that sterile pleural efi'usions f'rom two patients with acute 
lobar pneumon:i.a showed the pres�nce of inhibition of the drug, 
but s'krile blood serum f'rom sixteen patients oa.use no inh.ibi-. 
tion of the bacteriostatic etf'ect (49). 
Following up his clinical observations, MacLeod turned to 
the laboratory. He tested a num.ber of peptones too f'ourid the 
presence of sulfaoilaroi.cie inhibitor in all oasea. These 
peptones were obtained by the_enaymatic digestion of casein. 
He f'ound, however, that the lzydrol.ysates of casein prepared 
by heating with concentrated acid or alkali were entirely free 
of inhibitor.- He thus concluded that sulfanilamide inhibitor 
does not depend upon the presence of easily 11s_similable nitro­
gen since the ,acid . aJld alkaline hydrolysates of casein supply 
a srea.t excess of nitrogenous substances and yet care entirely 
free or sulf'anilamide�inhibiting acUon (49). In tt,sting
purul.ent exudates, he i'ound the presence of relatively large 
amounts of sulf'anil.amide inhibitor; •The presence of sulfanil­
am.ide inhibitor in.purulent e.xudates is not unexpected, since 
uoier these conditions considerable .autolysis occ-urs, al.Id &8
shown previously in the case of normal tissues, the amount ot 
inhibitor increases greatly during the autolytic process" (49) • 
.After having found the presenQe of' the inhibitor, MacLeod goes 
no further in .any explanation of the nature of the substance 
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other than to say that it is something other than the easily 
�ssimilable nitrogen which had been suggested by previous 
workers., Bliss has followed up this inhibitor idea a little 
further, and found the inhibiting properties, as shown by Lock­
wood, art shared by casein hydrolysates and certain combination 
or amino a,cids { 6) p ,J�ter testing e�ch essential. amino acid, 
Bliss £owxi that it was methionine that conststantly counter­
acted the effect or su.ltanilamide (6). He concludes that 
methionine is not bacteriostatic, but is probaCly the precursor 
of the substance which has ,antisulfanile.mide activity { 6) * 
.Atter studying the, structure or para....a.mino benzene suli,"on­
,amide, Selbie experimented with par.a-aminobenzoic ,acid and f'ounl 
that it wow.d inhi'bit the therapeutic action of sultanilamide 
{68) .. Lalldy .found, "The bacteriostatic effect, as measured in 
vitro, of sulfanilamide, sultapyridine, and. sulf'e.thiazole on 
:� 
streptococci, pneumococci,-ihd staphylococci respectively, has 
been found to be completel.y,neutraiized by p-e.minobenzoi� acid. 
This observation suggests that this neutralization mechanism 
is similar for any of the organisms and inhibitors investigated• 
(57) ,, Par,a.....aminobenzoic -acid is essential tor the growth ot 
the micr0:-0rganisms. Howe�e:r, Woods f'ound that this product is 
normally synthesized in sufficient quantity by the streptoco.cc� .. 
On the �bove bases, he suggested that •the enzyme reaction 
invoived in the further utilusation or p-iuiinobenzoic acid is 
subject to comparative inhibition by sulfanilamide, and that 
this inhibition is due to a structural rele.tionship between 
sulf'a.nilamide .nd p-aminobenzoic acid• (81). Fildes ., a co-worker 
oC Woods, suggests that the action of sulfanilamide is competi­
tionf'or an enzyme, associated with an essential metabolite, 
and that this essential. metabolite: is p-aminobenzoic acid (17}.
MacLeod confirmed. the observation of Woods -and Fildes on the 
•nnulling e£fect oC �nobenzoic acid on the bacteriostatic
action or the sull'anilamjde drugs, but states that the inhibi­
tors present in his en£ymatic digest of casein differ in
certain of their chemical properties f'rom p-aminobenzoic acid
(49), .Lockwood has stated that p-e.mino benzoic acid is an
essential. intermediary metabolite f'or bacterial cells; that the
cells can synthesize this f'rom the primary essential amino
acids or obtain it f'rom the environment; sulfanilamide is
chemioalJ.y close to the p-e.min�benzoic acid ani competes with
it £or molecular groupings on t;he bacterial protoplasm. Thus,
he stated, the metabolism oft� cell is inter:ferred with The
�o�nz�ic acid comes .from tt;he degenerating tissues (.B..-1).
Lockwood continues, "'There is no direct evidence that the
inhibitory affect ot pept.one a.I1(l of other proteolytic products
is due entir,.,l.y to their content at p-e.minobenzoic acid or ol
I
some structurally related material. However, there ls such cloa:J
similarity in the nature of the antisulf'anilamide effects of





these substances as to suggest that the same mechanism accounts 
for the sulfonamide-inhibiting properties of' proteolytic. 
products;w (B-1). 
Briefly, then we have traced the investig�tions of the 
anti-sult':anilamide activity from the beginning with peptone, 
to the theory of the essential..amino acids, specil'ical.ly methio­
nine, to the latest theory of' p-,e.minobenzoic acid- Most of 
the investigators f'ollOllfing .along the line of' Lockwood all seem 
to1coneent that the p�nobanzoic acid is the actual anti­
sulf:anile.mide compound for which they he.� 'been searching. The 
nut question �s just how does this acid function in tl:le 'bacter­
iostatic action of' the sulfonamide drugs. Even bef'ore his 
peptone idea was thoroughly under way, Lockwood concluded fros 
some of his experiments that, •Indirect evidence is ottered to 
suggest that sultanilamide.acts upon hmmolytic streptococci 
by interference with their protein...digesting mechanism (39). 
Bush states that the works of Lockwood, arid. Spink indicate, 
*that the drug int111r£ered. in some way- with the ability ot the 
enzymes of the micro-organisms to digest proteina• (12). Stamp 
suggested thal.t the anti-sulf'.-nil.amide £raction may contain&n 
essential. amino acid, or could be ,an essential part.a£ the 
enayme system .affected by the drugs {75}. Neter ia o£ the 
opinion that the latest.work with the drug illiio&tes that the 
cetion �. the drug is one c4, •competition with bacteri.al 
. ·. :j 
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enzyme systems associated with 1essential tnetabolites" {61). 
From these findings, we can conclude that, according to 
thi�the pres�nce of p-4i.!Ilinobenzoic aeid, or a precursor, is 
f'ound in the presence of protein ca.tabolism. 'I1his substance 
is expec:ially plentiful. in localized collections of cellular 
destruction. Because of the chemical preponderance of this 
substance it is able to combine with the cell in some manner in 
larger molecular numbers than a.re the sulf'onamide drugs, and 
thus able to exert an anti-su.i.fanilb.ill.ide action. Thus it is 
concluded that the action a£ sulfanil.amide and its deriv�tives 
is one of interfering with the protein metabolism ot the cell. 
Many are the suggestions that this action is actually due to 
an effect on the enzyme system of the bacterial. cell. 
However, this theory does not expla.in or contain all ot 
the £indings, and the negative side must �lso be presented. 
Long states that the drug may act either on the bacteria to 
prevent them from utilizing the substrate, or by altering the 
substrate so as to render it unavailable to the micro-organism 
{B-o}. His thwory wil.l be taken up in the next section. ?he 
investigations or Lockwood have been along the linBs of growth­
promoting substances; Long states that the addition of extrose, 
which is a1so a growth stimulant, showed no decrease in the 
bacteriosta.tic action or su.lfanilamide (B-5),, Long concludes 
that, 0RJ..s concerns the theory of Lev.aditi and Lockwood, it seems 
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that between the proteolytic power or virulent and avirulent 
streptococci, it shoui.d be regarded only as an interesting 
spt;cu.lation• (B-5)., Weld states, •Our experiments do not seem 
to support the theory that sulfani1£amide intert·eres with the 
power of streptococci to utilize serum proteins or that peptone 
per se interferes specitically with the lactericidal effective­
ness of sulf'.anilamide• (79}. Kalmanson could find no ef'tect 
of peptone in his experiments (5l.) .. Long found that in the 
presence or beet infusion brotb..:or 50 per cent normal horse 




Jll.\rked baoteriostattc .action on beta hanolytic streptococci 
(43).., Gay states, •Too sweeping. conclusions have hitherto been 
drawn from the study of a single var:iable factor, such .as an 
unfavorable temperature or the absence or presence of peptone• 
(25). It must be talcen into consideration, nevertheless, that 
the nE;g.ta.tive views that have been written were all aimed ._t 
the f inliings of Lockwood and his pep tone t"indings, and not at 
the :findings whichfoUowed the beginning work of Lockwood and 
nis co-investigators, viz., p-,aminobenzoic acid am enzyme effeot* 
The recent timings of the Lockwood group with the wealth of 
investigations, am ca.re in the work done cannot be dismissed 
so lightly� 
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.ACTION DIRECTLY ON THE BACTli..RIA 
III .. CATALASli: AND Ei�ZYME 
The first investigations al.ong the line o£ emymatic 
activity of suli'anil&mide was maa.e by Meyer, a Frenchamn who 
f'ound th&.t an intermediate oxidation product of the amino 
group, the hydroxyl.amine (NHOH} derivative of sul.tanile.mide 
wa� highly active in the test tube against streptococci. 
Meyer postulated the slow f'ormation in the body of tnis deriva­
tive as the basis for the activity o£ suli'anilamid.e (65). 
Shaffer states t�t sul.f'ann.amjde activity is not possible 
without the presence o£ oxygen (69} r ..Among the. ear1y invest{-
. 




decomposition or hydrogen peroxide is brought about by success-
ive reduction of the oatalase iron by the peroxide. He found 
among the inktj.bitors of the oataasa to by hyo.ro;xylamine which 
inhibits the reox.id.&tion or the reduced cata:i.ase by molecular 
oxygen {54)r 
Mellon is the leading investigator in.the United States 
of' the catalase theory.. The anti-catlil.se activit r of hydro�l-, 
amine had already been pointed out. 
meyer plus the observation that the 
Taking the f'indings of 
i 
bacteria af'!'ected by the \ 
drug were mrobic, he started investigating the oxidation or
eulf'anil.amide ., Mellon .found that, ttoxidation o£ the type 
produced by ultr•violet acting on -aqueous solution endows 
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sulf'anilam.ide with marked anti-ca.ts.lase pro�erties. It there-� 
f'or·e av1ears reasonable tc select· the i":Lrst step of' . oxidation, 
that is, the hyroxylamide: o.erivative, as the seat of activity" 
(57) .. (See section on chemistry.) Mellon pictures the conver­
sion of' sulfa.nilamide to anti-cat.lase by the pneµmococcus as 
follows: 
•The .above f'igure is ill.ustrative of the changes that we picture
as taking pl.ace when sul.£anU;amid.e di:ttuses through the capsule 
of the pneumococcus into the interior of the cell .. Under 
norJBi.l conditions biYdrogen peroxide is being elaborated.by the 
cell, btit.<is immed.iately destroyed by the enzyme catalase, 
which is .a.J.ways })l'esent, in its destru�tion into water and 
oxygen.. However, when the sult.anilamide is converted into 
anti-catalase (AC) by the oxidative processes in the cell, 
dit.fusion of' the catala.se f'rom the exterior is blocked, and this 
resul:t.s in the accumulation of peroxide, no:t·only in the cell, 
but in the surrounding medium" (56). Thus we see that he believes 
that the hyro;icylamine .M.riva.tive poisons the enzyme catalase, 
.which primary !"unction is to destroy the t� hydrogen "peroxide 
as soon .as it is liber.ated by the bacterium; the accumulation 
or the hydrogen peroxide accounts for the bacteriostasis. {56). 
Main formed the intermediar-.f oxidation derivative by t·he irrad� 
iation or sulfanilamide by ultr.aviolet light, :and :found a 
correlation 1:?etween the colored product produced .and the ;anti­
c&tlii.se activity. He thus concluded that it was oxidation 
which accounted for the •.activation• o.f the sulf'.anilamide (51). 
· Main is of the opinion that by the action of an anti­
oat;6se th� hydrogen pt:.roxide, • metabo1ic product, -.y reach 
high enough concentl"ation �ound the organism to retard further 
i • •• �. • 
growth(�)., Mellon demonetllated with :Pmllil"JDOCoccus c�tures 
containing• 10 mgm. of sulf'.an1lsmide that eydrogen }l8l'oxide did 
..actually accumulate; he tffliln added fresh peroxide comp&N.b1-
. ' 
. . 
to the con�entr.ation which 1 had accum\U.ated. in the cultures 
. . 
' 
under the :µif'luence of suJ.tanilaroide .and brought about a similar 
degree of bacteriostasis (56). He st.ates that his expertm.exi:t, 
•indica.tes that the uug must be converted. into some 'ba�terio­
atatic f or'1, but only .after the germs ha:ve started to grow in 
. 
' 
it app:recdAllblf ••·o.-.-this substa.nee is ey<iroql.udne, or aoae 
closely re�ted de_rivative (56). The results of locke 1 1
_experiment� .are, 11T.be pneuaococcus -and tbe _hanolyti.c strepte>­
coccus ba.v, the property of being -abl.e to produce peroxide 
without,-•� the same .time, being :able to prevent accUDNlation. 






elimination on catalase borr01red from the medium supporting 
gro,vth.. Cata.lases decompose peroxide am permit growth so long 
as they remain e.fficient. Th�are inactivated by hydroxyl­
Gline .am by substances related to hydroxylamine in structure 
or propertiee-1' (58). ·Locke found that, 11blockage o£ the pal'a­
amino group in sulf'.anil.am:lde, through acetylation, produces a 
degree �.·impairment in effectiveness parallel to the degree 
or impairment in susceptibility to oxidation effected"', and that 
more drastic oxidation to the p-nitroso is not effective (58) .. 
Mellon state�, as regards his theory, •The fact that su11'anila-. 
aide is capable or being converted by the germ itself into the 
anti-cayal.ytic hydroql.amine derivative, is a most important 
.tact in connection with the drug's mode of ,t.ction .. It means 
that its conversion into the active form need not be brought 
. i 
.about by the cells of the host, a fact which appes.rs to be of 
. i 
cardinal importance owing to the great ins'ttbility of the cactive 
form per se .. That is to say, if' the conver�ion to the hydrox­
ylamide derivative were not capable of being made by the germ, 
, I 
but only by the host cells, it would pl'obab�y be broken down 





so it could be effective• (56), In measuring the detectable 
peroxide in control and sul.fanilamide cultures, Mellon found 
that tor the first three hours the content was s&bout the sam&J 
however, :after re�tlon or growth was apparent in th� 
.J 
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sulf'anilam.i.de cultures, the amount of peroxide .accumulated 
al.though the growth was becoming less than the controls. This 
snowed an increasing .amount o:f peroxide per unit of bacterial 
substance... Continuing .his experiment, ;af'ter a .five hour period, 
he -added to the control the same concentration of peroxide •s 
he had in the su.lfanilamide cultures and got the same degree 
of baoteriostasis as was produced by the sulfanilami.de (57). 
In studying the Eh (pc:,tentitl) o:f the cultures, Mellon fown 
the elevation in the potential to be consistent with his fim.ings 
of increased. peroxide production in the presence or. sult.nil­
ami.de; he .also found that the l.owering effect or catala.se on 
the potential to be.opposite o:f the el.evating efi'ect of the 
anti-catalytic sulfanilamide., This e1evation of the Eh is brought 
about �Y the peroxide accumulation (57)., Mellon is of the 
opinion, •that sulf.a.nilamide is inactive toward highly virulent 
bacteria until it is partially oxidized to stages whose chemical. 
properties make £or inactivation of the germ's enzyme thereby 
interi'ering with their food suppl.y; an accompanying et"fect of 
this starvation process is to permit the accumulations of their 
own excretory products of which the toxic }:zydrogen peroxide 
'is one"' (55) ., He believes that due to the action of the drug 
on the bacteria, that there is a resultant phase-transformation 
which brings the germ within killing range of the immuno­
phagocytic dei'enses of the host (58); and that this is brough� 
'- -
-a.bout by the act.ion or the drug on catalase as well .as peroxydase,
·certain dehydrogenases, and nitratase, thus seriously affect-_
ing the nutrition of the bacteria (57) •
. The Eh (potential) of' cultur1;.:s wa� studied by Fox who
f'ound that the Eh or mrobic sultanilrunide-cultures remained 
elevated much longer than control culture.a, but that when 
bacteriosta.sis ceases, the Eh al.so .£ell (22).. Hewitt f'ound that
(l} addition of' catalase inhibits peroxide formation in cultures 
0, hamol,Jtic streptococci, and (2) addition· of ca:tala�e to -a 
culture containing peroxide causes .an immediate -and r-apid taU 
in potential (29). He :al.so f'ound that the organisms are appar-. 
ently not injured by the peroxide in low concentrations (ta}.
Th us we have more indirect evidence that the action at the 
sultanilamide is one of anti-catalytic activity.. warren found 
that the 84dition of sult-anilamid.e to cultures was ,accompanied 
by an elevation ot the oxida:t.ion-reduction potential.J that 
compounds related to sult'-.nilami.d.e but lacking in 'b&cterloatatio 
action a.re without et£ect upon the culture potentials• (78}. 
This f'inclilli shows that the action of the drug would aeem to 'be 
on the bacteria, resulting in an increase of peroxide, r.ather 
tl'laJ» a direct etf'ect on the catale.se. 
The earl.y work of Shinn showed that there was an accumu-
lation of eydrogen piroxide in the zoDe immediiatel.y suno�ing 
. . 
the cultures (70). He .agrees that the mechanism o£ s-ulfanil.-
... __... 
.amide action is in part through the inactivation of catalase 
(70), but states that part ot the action is due to the sulfonamvio 
group expecially UDder anerobic conditions {71)., In a later 
experiment, he was um.ble to detect any eydrogen peroxide in 
cul.tures which contained no sulf.anihmide {71.) .. Shinn states, 
nunder normal. conditions the amount or pxygen present in plasma 
is .adequate for support ot -a high degree or inhibition., The 
depe ndence or sul.f.anilr.mide upon oxygen imioates the advm­
bility of maintaining or increasing, where possible, the oxygen 
suppl.y at the 1esion• (71.). Fox strengthened this point when 
he t"ound that oxidation by simpl.e ,aez: .. tion or ,a culture favored 
oxidation aild prevented reduction (21).  Main Cound the con­
centration of peroxide per uirl,t of growth wa11 from two to ten 
times greate,r in the presence of compounds which caused bacter­
iostasis than in control cultures (52}., ilong with the accum­
ulations of peroxide, McKinney found other evidences of dimin­
ishing metabolic activity-fermentation of inulin, and. decreased 
virulence (48) ., Morgulis (ot this campus) found that, •by 
making the hydrogen perwtide concentration high enough, the 
catala&e reaction could be practically stoppedff {59). 
In doing blood oatalase determinations in 21 patients, 
Clyman £oll!ld in the £ifteen patients receiving suli'ona.�ide drugs 
a definite depression ot the blood catalase activity; while the 
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•,; 
concentr.a.tion of hydrogen peroxide is not high enoUgh, in the 
sulfanilamide cultures, to .account. for the decrease of the growth
of tbtl organisms.. Long critciaes the ca.talase theory by saying 
that peroxide concentr.ation should kill in a cats.lase-poor 
media, but did not find this to be so; also that the henolytic 
streptococ9i vary enorhlously in their ability to produce pera&id.e, 
but that thare is no correlation between their production ot 
peroxide and their senaLt;ivity to sultanilamide (B-3)" 
The last statement by Fox ( two paragraphs bef'ore) brings 
U!J the question ot enzymes in general.. .All ot the material. 
presented previously bas to do with one specific enzyme­
oatalase .. Lewis states that the :action of sultanilamid.e is, 
•It inhibits the growth of the bacteria, probail.y by interferin.J
with their metabolic enzymes, especially the OJtidases• (B-o). 
Mclinney l.ists the enzymes .r:rected o&s cata1ase, perox;ydase, 
de�ogenases, .and nitratases, &s well as proteolytic ens�• 
(48). Broh-lahn found that sulfanilam:i.de prevents th� oxidation 
ot lactate by nitrate (10)., Lord stats, 110ne explanation ot 
this bacteriostasis is that it is du� tn part to impairment of 
the nutrition of the bacterial cell through inhibition of an 
enzyme or enzymes• {B-2). 
Bacteria, just like the more highly integr"9.ted species, 
satisfy their nutritive requirements through the elaboration 
,and. &ctivity of enzymes. This enzymatic activity involve, a 
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series of chemical. re1wtion ta.king 9lace near or on the surf'ace 
of the bacterial cell .. The bacteria ll)G.nnot grow in media which 
is either deficient in any of a number of essential metabolites 
or it the enzymes through which these materials a.re utilized 
b�come physically or chemically inactivated. Since the suli'ona.:aide 
drugs allow the bacteria to grow for a short time and :then': rath3r 
abruptly terminates the logarithmic phase of growth, it would 
seem that the effect is an interruption of a.n essential nutri-
ti�e process at a level of population much lower than that which 
the medium would otherwise support. Woods bt:lieves that the 
enzymatic rea.tion involved is in the synthesis of para-amino­
benzoic acid by virture of its chelilical similarity to the product 
of the reaction (81). 
There is one question that remains, .and that is the 
sel.ectivity or the suJ..tonamide drugs., Various species of 
bacteria. hb.ve various enzymatic systen1:s .. The selectivity of 
the drug for these various enzymati systems in not unusual. 
We have Sb.lts, basic dyes, and acridine dyes which are all 
sel.ective for various types o:f bacteria.. Broh-Kahn says that 
suli"anilamide selectively inhibits only .certain mechanisms (lo}. 
In summary, we aee that cultures treated with sulfanil­
amide show a higher concentration of hydrogen peroxide than the 
control cultures. This is due to the anti�catalaee activity 
. 
of the drug. There is a correlation between the action ot the 
·-- . . _: -:- · ......  _ 
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oxidation derivative of sul.tanilsmi.de &Di the .action of sulfa-
. nUamide; therefore, the �ctive -agent or the drug is the inter­
mediary oxidative derivative,· The raising of the Eh also. 
points ·to the oxidation theory of t-he drug. .Animal observations 
show a decrease of catalase activity under sull'anilam:l.de 
therapy, The bacteria df'ected by the drug are the &3l'obes, and 
it is this arobic condition which is necessary for the ef'f'icacy 
of the sulfonamides. There are many concurrent observations 
whieh show disturbences in the metabolic processes of the 
bacteria, Many of the findings suggest that the action ot the 
drug_is directly on the enzyme system ot the cell •hich results 
in an indrease in the concentr.ation of the peroxide, and that 
the eff'ect on the catalase is secondary to the other changea 





� quick resume or the gene&l observations or the action 
or sulf'anilamide rev�ls that there is an action on hamolytic 
streptococci resulting in a decrease in the growth r,ate, after 
a lag phase, -and• protl:lction of animal.a against the infection. 
This :phenomenon is brought about by bacte:d.ostaais. The drug 
is effective in those infections which are airobic am or a 
general.ized cbar.acter; localized areas or tissue necrosis 
maintain the infectious !f'ocess with little hindrance from the 
drug. Cultures under the inf'luence or sulf'anilandde show a 
change in the phase to a less virulent form. 
It has been found that blood with a given concentI,ation 
of sulf'anilami.de has higher bacteriostatic po¥Jer than has broth 
with an equal concentration. It has been propoaed\by severi.l 
investigators that the action of the drug ws:s to increase 
pha.gocytosis. Howevlilr, the vast maj�rity or the investigators . 
are against the theory or effect on the body defenses. Their 
evicience is that there is actually a mild leucopen:La produced 
• 
I 
with the .adniinistr.ation of the drug; the cyto1ogic response of 
the reticulo-eaiothe.lial. system is not a1tered by the drugJ 
the lack of immunity is not helped by the use of the sulfonamida1, 
It therefore seems that the cleaning up of the bacteria is not 
due to the er.teat di.re�tly on the body de.fe:qses, but rather that 




to the bacteria, and t.b&t this action permits a more ef'f'ective 
phagocytic activity of the body .. 
Of course, this action could easily be due to the neutral­
ization of the bacterial. toxins by th8 drug and thus decreasing 
the to .. dcity of the phagocytes.. There is f'oum a definite 
decrease in the toAicity of patients wxler the medication with 
the sulCona.mides. However, the evidence is strong and over­
whelming against any dµ-ect action of the suJ.£onami.de drugs on 
the neutrtlization or the bacterial to:xins.. Again, the action 
of the drug is one or decreasing the toxin output of the baeteri& 
by directly aff'ecting the bacteria. 
One of the best points :for the direct action of the drug on 
the bact�ria was made when McK.inl.ey said, •These neg�tive resul.ta 
with sultanilamide in treating experimental virus infections 
raise certain qubstions regarding the mode of action of this 
drug ... .,...,It is suggested that sul.f'.anilamide is unable to exert 
its action against the infecting agent when it has inv.ded ti. 
tissue cells as in the case o£ virus infections .. The efficacy 
� sultanilamide in specific bacteri.a.l. diseases may deperd 
partl.y on its successful attack against extracellul.e.r organisms, 
while the host cells the�elves are contributing to the defense 
.against invading microbes" (47} .. The opinion at Marshall i.a, 
•,At present, the balance qf evidence would seem to indicate tbat 
sulf'tnil&.mid.e .aff'ects the invading bacteria in the sense of · 
V 
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exerting a bacteriostatic or bactericidal action which is not 
sut'£icient to effect stel'ilization without the co-operation 
or the defense mechanism ot the host"' (53)., Keeter summarized., 
•sulf'.anila.mide inhibits the growth ot organisms and prevents
overwhelming intoxication until the defense m�chanism �n be
mobilized and finally bring about recoveryn (52). Further
evidence for the location or the effect being on the bacteria
is the clinical. observation that the .administration of the. ·drug
al.tt:rs the picture of blood cultures and bacterial· typing. Roth
. 
is of the opinion tbi..t since there is a long latent period before
securing -an effect with sw..Canilamide that it is doubtruJ. that
the drug directly affects the cause of' the disease (66).· However,
this objection can adequately be explained by the theories of
direct bacterial. action.
In recapitulation of the foregoing observ.ations., it seems 
possible to concl.ude that sulf'anilamide does not-arouse• 
specific response on the part or the host.. The producti.on of 
;antibodies is not stimulated, .and there is no direct act.i.on 
upon the phagocytic mechanism., The more recent investigations 
pl.us the number of investig.ators gives considerable weight to 
the evidence tbat the drug does act upon the micro-organisms 
in v;Ltro and in vivo, Most of the workers are of the opinion 
that this •ction takes the form or an inhibition or the growth
ot the bac1;eria which thereby permits the defense mechanism 
, I 
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or the host to -accompl.ish its f'unction. So tar the evidence 
presented has ruled out the direct ef'f ect on p.hagocytosis .and 
the body defense13, .and it is stil1 n�cessary to find a positive 
explanation for the inhibitory .action or the drug bf dir�ct e.t'fect 
on the bacteria.-
In studying the chemistry of sull'anilamide, it was shown 
that the components are: the �nzene ring, the amino radical, 
and the sulfonamide r,adical. The two must be in para positions, 
not to make it bacteriostatic, but because it is the only 
form that the body can band.le. The amino group ·is the more 
important, but the sulfur in the sulfonamide r.adioal is aleo 
essential. The possibl.e chemical f'&te of the molecule •• 
ahown; __ the intermediate oxidation derivative---hycirox;yl.am1na­
is the f'orm that we .are most interested in .. 
Relative to the -action of the sulfonamides on the bacteria, 
. . 
the peptone theory was the first pre1:1ented. The background tor
this idea is that with luge inocula or with locali&ed. :Lntectiou, 
I 
such .as abscesses, the drug is only slightly ef'f'ective. .lt 
f'irst it •s thought that peptone •s responsible for the 
intert"erence with the .action of sulfa.nil.amide; but further work 
. . 
indicated �t one of the essent:ial amino acids .actuall1 waa 
involved .. This acid ws later found to be methionine, which is 




by other workers that p-aminobenzoic acid had & much more de:tinite 
action in the inhibition of sulf'anilamide.- Because or the very 
close chenical relationship, it is thoUght that the two compounds 
compete with each other f'or groups in the bacteria protoplasm. t­
The p-e.minobenzoic acid ..appears to be an essential. intermed.tary 
metabolite, which is necessary for the c�lls to obtainJ it inter­
feres with the ..action or the drug when its moleculs.r number is 
greater than that or the drug. It will be noticed that• number 
ot th€ investigators have mentioned that the drug has the effect 
of interfering with the metabolism of the micro-orga.nisBlB, -.ncl 
several. say that this efl'ect is tbroug� the enzymes. 
The catal.11.se theory of action on the germ states tha.t the 
intermediate oxidation product has the e:tfect or nullityina tb.a 
-action or the ca:t.a_.., This catal.ase .has as its f'unction · ..
the breaking down or thtt peroxide which has been formed by the
' -
metabol.ism or the cell., When this takes place, t� el,evat.84 :: . r.
concentr,ation of the peroxide causes a disturbance in the cellulla2'' 
·, \ 
metabolism. The elevated Eh shows that this action is taking
place ur:der oxidative conditions. It was shown that there w.s
.;a, decrease in the oa.talase activity of the blood under suJ.ra-, 
nil.amide ther.apy; and that the increased concentration ot
biYdrogen peroxide would cause a be.cteriostasis in itslef. It 
will :again be noted that the majority of the worker� mention. 





that the indications point toward ,a general enzymatic action.,
H;ydrogen peroxide itself shows an anti-cat.a.lase ,activity, and 
it is probable that the action is one -.using a primary greater 
:i;,roduction of. the p.:roxide, am a secondary effect on the 
oatalase. 
Tht:l two theories, on the face, appear to be very widely 
separated.- The positive finclings in each. case cannot be denyed .,
To correlate them seems at first impossible.· The more recent 
timings in the peptone theory point to a specif',ic compound 
being involved, the abumance of which will nullity the action 
of the drug, but the .abundance of the drug seems to interfere 
with the action of t�s p-4llllinobenzoic acid., In infections 
locallzed,snowing a nul.l.ifying ettect, the oxygen tension 11 
low •. ,A lack of necrotic tissue, with its abundant nitrogenous 
materieJ., is alos a condition in which oxyien tension is high 
. , 
enough to show an anti-ca't41:lase effect., The latest findings 
indicate that the action is one connected wit.h a chemical 
blockage of some enzyme which is necessary fo� the metabolism 
. of the cell..- The cata1ase theory ·sp.ows the action of sultanilard.de 
to invol.ve .a specific enzyme, or at least gives the s&.me results 
as though it bad acted on· this enzyme. However, incident&l 
tindiIJgs showed that other enzymes were � �teated. It thua 
&ppears_tbat both of the tlleoriec:1 are brought together f1 the
. I 
c,¢.nion expreosed by each that the actual oftect is onerdirectq' 
• 
·, ,-�- .- �-� . ...... 
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on the enzymes of the bacterial cell. This action is meni:f'ested 
by (l} the accumulation of hydrogen peroxide, because:the 
ca.ta.lase is blocked at the bacteria, and (2) the disturbed 
nutrition shc,wn by changes in phase and virulence. 
For the effectiveness of the drug, the bacteria affected 
must be under a:z-obic conditions with onl.y e. relatively small 
runount oi' necrotic tissue present. Under these conditions the 
drug produces demonstrable disturbances in aetabolism and a
increased concentration of hydrogen peroxide. These two phen­
omena are caused by a cnemical blockage of the enzyme system .. 
Since the effects ar� ma.nif'est only under favorable mrobie 
conditions, it is pretty sai'e to speculate that the specific 
enzymes are those aBsocia.ted with the respiratory system of the 
bacterial cell. However, the final proof of this s;,eculation 
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